Label Changes for:

Altabax (retapamulin) ointment

September 2010

Changes have been made to the WARNINGS and PRECAUTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – September 2010

 

WARNINGS AND PRECAUTIONS

Not for Systemic or Mucosal Use subsection
  • Epistaxis has been reported with the use of Altabax on nasal mucosa
Hide
(web5)